1 / 10

Drug Eluting Balloon Market

Drug Eluting Balloon Market<br>

rishabhCMI
Télécharger la présentation

Drug Eluting Balloon Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Coherent Market Insights Market Research and Business Consulting Services https://www.coherentmarketinsights.com/ COVID-19 Impact Tracker

  2. DRUG ELUTING BALLOON MARKET ANALYSIS • Drug Eluting Balloon Market - Global Forecast to 2026, by Product Type (Coronary Drug Eluting Balloon, Peripheral Drug Eluting Balloon, and Others), by End User (Hospitals, CATH Laboratories, Ambulatory Surgery Centers, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2018 – 2026

  3. Drug eluting balloon plays a major role in modern healthcare, as it homogenously delivers medication to the vessel and prevents neointimal hyperplasia. • The global drug eluting balloon market size was valued at US$ 420 million in 2017, and is expected to exhibit a CAGR of 8.1% over the forecast period (2018 – 2026).

  4. Increasing prevalence of coronary artery disease and diabetes is expected to propel growth of the drug eluting balloon market • Drug eluting balloon is an angioplasty balloon, which plays a vital role in treatment of coronary artery disease. High prevalence of coronary artery disease is expected to propel demand for angioplasty and other treatments, which in turn is expected to drive the market growth. According to the World Health Organization (WHO), around 3.8 million men and 4.4 million women die, annually from coronary heart disease worldwide. Moreover, the number of deaths from age 15 to 59 is around 1332 thousands and for above 60 years of age is around 5825 thousands. • Diabetes can damage blood vessels and nerves associated with heart and can lead to cardiovascular disease. Therefore, increasing prevalence of diabetes is expected to propel growth of the drug eluting balloon market over the forecast period. For instance, according to WHO’s, October 2018 report, around 1.6 million deaths are registered due to diabetes globally. Moreover, the global prevalence of diabetes among adults over 18 years of age is estimated to increase from 4.7% to 8.5% from 1980 to 2014. The adoption of drug eluting balloon is majorly preferred by surgeons due to its effective treatment of peripheral artery and coronary artery diseases.            • However, adverse effects such as coronary artery lesion and lumen enlargement are expected to hinder the market growth. For instance, in May 2017, Abbott recalled three balloon catheters due to difficulty in removing balloon sheath, which caused 19 reports of injury and 1 death.

  5. Increasing adoption of drug eluting balloon in North America is expected to bolster the market growth • North America holds dominant position in the global drug eluting balloon market, owing to high prevalence of obesity, which further develops cardiovascular and coronary artery diseases. In October 2017, according to the National Center for Health Statistics (NCHS), estimated the prevalence of obesity in adults was around 39.8% and in youth 18.5% in the year 2015 -16 in the U.S. Increasing prevalence of cardiovascular diseases developed from tobacco and smoking in the region is also expected to boost the market growth. •  Similarly, according to WHO, in March 2018, around 7 million death were recorded due to tobacco use in which round 890,000 were due to second hand smoke globally. • Moreover, increasing geriatric population that is prone to cardiovascular diseases is expected to propel demand for angioplasty, which in turn is expected to boost the market growth. For instance, according to CDC, in May 2016, around 19% of the population in the U.S. is projected to fall in the geriatric category by 2030. Moreover, in the U.S., around 40 million individuals above 65 years and above are affected by cardio vascular diseases.

  6. Key Players • Major players operating in the global drug eluting balloon market include, Medtronic, Becton, Dickinson and Company (BD), Boston Scientific Corporation, Cook Medical, B. Braun Melsungen AG, Koninklijke Philips N.V., Opto Circuits (India) Limited, Terumo Corporation, Surmodics, Inc., and Biotronik.

  7. Request Sample Report • Request Customization • Download PDF Brochure • Talk to Analyst • Buy Now Reference: https://www.coherentmarketinsights.com/market-insight/drug-eluting-balloon-market-2459

  8. About Us Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. What we provide: • Customized Market Research Services • Industry Analysis Services • Business Consulting Services • Market Intelligence Services • Long term Engagement Model • Country Specific Analysis

  9. Contact Us Mr. Shah Coherent Market Insights Pvt.Ltd. Address: 1001 4th Ave, #3200 Seattle, WA 98154, U.S. Phone: +1-206-701-6702 Email: sales@coherentmarketinsights.com

  10. Thank You! Kindly follow CMI Social Media Profiles for the latest company updates Facebook Linkedin Twitter https://www.coherentmarketinsights.com/

More Related